{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:53:18Z","timestamp":1790023998630,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Prof. Jan Veltkamp Fonds of the LUMC"},{"name":"The Dutch Arthritis Foundation","award":["LLP-24"],"award-info":[{"award-number":["LLP-24"]}]},{"name":"IMI JU funded project BeTheCure","award":["115142-2"],"award-info":[{"award-number":["115142-2"]}]},{"name":"Foundation for Research in Rheumatology (FOREUM)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.joca.2017.01.018","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T10:30:39Z","timestamp":1486549839000},"page":"1150-1160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Targeted lipidomics reveals activation of resolution pathways in knee osteoarthritis in humans"],"prefix":"10.1016","volume":"25","author":[{"given":"H.S.","family":"J\u00f3nasd\u00f3ttir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Kwekkeboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.J.","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kloppenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.M.","family":"Toes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Giera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ioan-Facsinay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2017.01.018_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/ard.2010.131904","article-title":"Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review","volume":"70","author":"Yusuf","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2017.01.018_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","article-title":"Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)","volume":"21","author":"Berenbaum","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2017.01.018_bib3","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1136\/annrheumdis-2013-205003","article-title":"Inflammatory ultrasound features show independent associations with progression of structural damage after over 2 years of follow-up in patients with hand osteoarthritis","volume":"74","author":"Kortekaas","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2017.01.018_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri915","article-title":"Anti-inflammatory lipid mediators and insights into the resolution of inflammation","volume":"2","author":"Lawrence","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.joca.2017.01.018_bib5","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1182\/blood-2014-03-562710","article-title":"Resolution of acute inflammation bridges the gap between innate and adaptive immunity","volume":"124","author":"Newson","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.joca.2017.01.018_bib6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.plefa.2010.02.003","article-title":"Resolvins and protectins: natural pharmacophores for resolution biology","volume":"82","author":"Levy","year":"2010","journal-title":"Prostagl Leukot Essent Fat Acids"},{"key":"10.1016\/j.joca.2017.01.018_bib7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.joca.2017.01.018_bib8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2\u2013nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.joca.2017.01.018_bib9","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.joca.2017.01.018_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/srep00639","article-title":"Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA","volume":"2","author":"Fredman","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.joca.2017.01.018_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.smim.2015.03.004","article-title":"The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution","volume":"27","author":"Serhan","year":"2015","journal-title":"Seminars Immunol"},{"key":"10.1016\/j.joca.2017.01.018_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1465-9921-11-71","article-title":"Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma","volume":"11","author":"Bhavsar","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.joca.2017.01.018_bib13","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s12035-015-9544-0","article-title":"Pro-resolving lipid mediators improve neuronal survival and increase A\u03b242 phagocytosis","volume":"53","author":"Zhu","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.joca.2017.01.018_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2013.12.024","article-title":"Resolution of inflammation is altered in Alzheimer's disease","volume":"11","author":"Wang","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.joca.2017.01.018_bib15","doi-asserted-by":"crossref","first-page":"e55859","DOI":"10.1371\/journal.pone.0055859","article-title":"Proresolution lipid mediators in multiple sclerosis\u2014differential, disease severity-dependent synthesis\u2014a clinical pilot trial","volume":"8","author":"Pr\u00fcss","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.joca.2017.01.018_bib16","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.2500\/ajra.2011.25.3726","article-title":"Cyclooxygenase 2 and lipoxin A4 in nasal polyps in cystic fibrosis","volume":"25","author":"Rozsasi","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.joca.2017.01.018_bib17","doi-asserted-by":"crossref","first-page":"e39244","DOI":"10.1371\/journal.pone.0039244","article-title":"Up-regulation of annexin-A1 and lipoxin A4 in individuals with ulcerative colitis may promote mucosal homeostasis","volume":"7","author":"Vong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.joca.2017.01.018_bib18","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and protectins in inflammation resolution","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.joca.2017.01.018_bib19","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbalip.2010.08.002","article-title":"Specialized pro-resolving lipid mediators in the inflammatory response: an update","volume":"1801","author":"Bannenberg","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.joca.2017.01.018_bib20","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","article-title":"Specific lipid mediator signatures of human\u00a0phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators","volume":"120","author":"Dalli","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.joca.2017.01.018_bib21","doi-asserted-by":"crossref","first-page":"12746","DOI":"10.1073\/pnas.1404372111","article-title":"Phospholipase A2 regulates eicosanoid class switching during inflammasome activation","volume":"111","author":"Norris","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.joca.2017.01.018_bib22","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.39279","article-title":"Low-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkers","volume":"67","author":"Attur","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.joca.2017.01.018_bib23","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0140-6736(82)92785-4","article-title":"Leukotriene B4, an inflammatory mediator in gout","volume":"320","author":"Rae","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.joca.2017.01.018_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/ard.60.6.627","article-title":"Raised levels of F(2)-isoprostanes and prostaglandin F(2\u03b1) in different rheumatic diseases","volume":"60","author":"Basu","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2017.01.018_bib25","first-page":"546","article-title":"Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines","volume":"29","author":"He","year":"2002","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2017.01.018_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/ar2717","article-title":"Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids","volume":"11","author":"Gheorghe","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2017.01.018_bib27","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbalip.2012.07.011","article-title":"Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC\u2013MS\/MS","volume":"1821","author":"Giera","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.joca.2017.01.018_bib28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10337-014-2779-5","article-title":"An advanced LC\u2013MS\/MS platform for the analysis of specialized pro-resolving lipid mediators","volume":"78","author":"J\u00f3nasd\u00f3ttir","year":"2015","journal-title":"Chromatographia"},{"key":"10.1016\/j.joca.2017.01.018_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ab.2013.12.030","article-title":"Minimizing artifactual elevation of lipid peroxidation products (F2-isoprostanes) in plasma during collection and storage","volume":"449","author":"Barden","year":"2014","journal-title":"Anal Biochem"},{"key":"10.1016\/j.joca.2017.01.018_bib30","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1194\/jlr.M058677","article-title":"Phenotyping drug polypharmacology via eicosanoid profiling of blood","volume":"56","author":"Song","year":"2015","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.joca.2017.01.018_bib31","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1073\/pnas.0402531101","article-title":"Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress","volume":"101","author":"Mukherjee","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.joca.2017.01.018_bib32","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.joca.2017.01.018_bib33","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.joca.2012.08.027","article-title":"Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review","volume":"20","author":"de Lange-Brokaar","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2017.01.018_bib34","first-page":"704","article-title":"Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis","volume":"32","author":"Marcouiller","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2017.01.018_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2014.05.043","article-title":"Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice","volume":"86","author":"Klein","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.joca.2017.01.018_bib36","doi-asserted-by":"crossref","first-page":"18433","DOI":"10.1523\/JNEUROSCI.4192-11.2011","article-title":"Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1\/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1","volume":"31","author":"Park","year":"2011","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.joca.2017.01.018_bib37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1476-5381.2011.01345.x","article-title":"The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats","volume":"164","author":"Lima-Garcia","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.joca.2017.01.018_bib38","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20132011","article-title":"18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload\u2013induced maladaptive cardiac remodeling","volume":"211","author":"Endo","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.joca.2017.01.018_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.plefa.2016.03.004","article-title":"Specialised pro-resolving mediators of inflammation in inflammatory arthritis","volume":"107","author":"Barden","year":"2016","journal-title":"Prostagl Leukot Essent Fat Acids"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458417308397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458417308397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:45:48Z","timestamp":1761018348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458417308397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1063458417308397"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2017.01.018","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted lipidomics reveals activation of resolution pathways in knee osteoarthritis in humans","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2017.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Osteoarthritis Research Society International. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}